Loading...

APC/Cyanine7 anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_APCCyanine7_CD45_Antibody_013019_updated.png
C57BL/6 splenocytes were stained with CD45 (clone 30-F11) APC/Cyanine7 (filled histogram) or Rat IgG2b, κ APC/Cyanine7 isotype control (open histogram).
  • 30-F11_APCCyanine7_CD45_Antibody_013019_updated.png
    C57BL/6 splenocytes were stained with CD45 (clone 30-F11) APC/Cyanine7 (filled histogram) or Rat IgG2b, κ APC/Cyanine7 isotype control (open histogram).
Compare all formats See APC/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
103115 25 µg 79€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103116 100 µg 157€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Additional Product Notes
BioLegend is in the process of converting the name APC/Cy7 to APC/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our APC/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  2. Naito H, et al. 2020. Nature Protocols. 15(3):1066-1081. PubMed
  3. Xing J, et al. 2021. Cell Reports. 35(12):109205. PubMed
  4. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  5. Contijoch EJ et al. 2019. eLife. 8 pii: e40553. PubMed
  6. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  7. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  8. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  9. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  10. Heindl S, et al. 2021. J Exp Med. 218:. PubMed
  11. Stefkovich M, et al. 2021. Mol Metab. 54:101357. PubMed
  12. Wang Q, et al. 2020. Radiat Environ Biophys. 59:89. PubMed
  13. Kim MY, et al. 2021. JCI Insight. 6:. PubMed
  14. De Vries LCS, et al. 2021. J Crohns Colitis. 15:617. PubMed
  15. Bernasconi R, et al. 2021. EMBO Mol Med. :e14392. PubMed
  16. Miranda K, et al. 2022. iScience. 25:104994. PubMed
  17. Da Mesquita S, et al. 2021. Nature. 593:255. PubMed
  18. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  19. Ren Y, et al. 2021. Am J Transplant. 21:552. PubMed
  20. Hilfenhaus G, et al. 2021. Cancer Res. 81:619. PubMed
  21. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  22. Cohen K, et al. 2021. Cell Rep. 37:110026. PubMed
  23. Schnell A, et al. 2021. Cell. 184:6281. PubMed
  24. He D, et al. 2022. Immunity. 55:159. PubMed
  25. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  26. Goncharov NV, et al. 2022. J Evol Biochem Physiol. 58:230. PubMed
  27. Li DD, et al. 2022. J Cell Mol Med. 26:2438. PubMed
  28. Denorme F, et al. 2022. J Clin Invest. 132: . PubMed
  29. Tang Q, et al. 2022. Mol Ther. 30:2709. PubMed
  30. Chae CS, et al. 2022. Cancer Discov. 12:1904. PubMed
  31. Miyao T, et al. 2022. Elife. 11: . PubMed
  32. Serra M, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:609. PubMed
  33. Poh AR, et al. 2022. Sci Adv. 8:eabl7882. PubMed
  34. Campisi L, et al. 2022. Nature. 606:945. PubMed
  35. Kenigsbuch M, et al. 2022. Nat Neurosci. 25:876. PubMed
  36. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  37. Li F, et al. 2022. Gut Microbes. 14:2096989. PubMed
  38. Rodrigues PB, et al. 2022. Cells. 11: . PubMed
  39. Zhu J, et al. 2022. Research (Wash D C). 2022:9816272. PubMed
  40. Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed
  41. Zhu X, et al. 2023. Adv Mater. 35:e2207198. PubMed
  42. Li S, et al. 2022. Nat Commun. 13:7371. PubMed
  43. Morrow RJ, et al. 2022. Cells. 11: . PubMed
  44. Liu P, et al. 2023. Clin Immunol. 246:109212. PubMed
  45. Alula KM, et al. 2023. Sci Rep. 13:18. PubMed
  46. Peng Q, et al. 2023. EMBO Rep. 24:e56034. PubMed
  47. Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed
  48. Zhou J, et al. 2023. Nutrients. 15: . PubMed
  49. Slusarczyk P, et al. 2023. Elife. 12: . PubMed
  50. Cao Y, et al. 2023. J Inflamm Res. 16:343. PubMed
  51. Tsioti I, et al. 2023. J Neuroinflammation. 20:25. PubMed
  52. Li XF, et al. 2023. J Exp Med. 220: . PubMed
  53. Chun J, et al. 2023. Cancers (Basel). 15: . PubMed
  54. Drummer C, et al. 2023. Front Immunol. 14:1113883. PubMed
  55. Ishikawa T, et al. 2023. Bio Protoc. 13:e4588. PubMed
  56. Ryan CB, et al. 2022. Neurobiol Dis. 163:105608. PubMed
  57. Marsh SE, et al. 2022. Nat Neurosci. 25:306. PubMed
  58. Gomez-Salinero JM, et al. 2022. Cell Stem Cell. 29:593. PubMed
  59. Hailemichael Y, et al. 2022. Cancer Cell. 40:509. PubMed
  60. Ren D, et al. 2022. STAR Protoc. 3:101217. PubMed
  61. Korsunsky I, et al. 2022. Med. 3:481. PubMed
  62. Cheng C, et al. 2022. Cell Mol Gastroenterol Hepatol. 15:261. PubMed
  63. Pattwell SS, et al. 2022. Sci Adv. 8:eabo6789. PubMed
  64. Schroeter CB, et al. 2022. J Neuroinflammation. 19:270. PubMed
  65. Ho HM, et al. 2022. Pharmaceutics. 14:. PubMed
  66. Cai Z, et al. 2023. Adv Sci (Weinh). 10:e2207155. PubMed
  67. Banerjee K, et al. 2023. Eur J Immunol. 53:e2250161. PubMed
  68. Wu Z, et al. 2023. EMBO Rep. 24:e56524. PubMed
  69. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  70. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  71. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  72. Tang C, et al. 2023. Nat Commun. 14:1493. PubMed
  73. Saha S, et al. 2023. Sci Rep. 13:4609. PubMed
  74. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  75. Freitag PC, et al. 2023. Mol Ther Methods Clin Dev. 29:120. PubMed
  76. Thai LM, et al. 2023. iScience. 26:106477. PubMed
  77. He Q, et al. 2023. Parasit Vectors. 16:139. PubMed
  78. Sasaki L, et al. 2022. Nat Aging. 2:105. PubMed
  79. Haensel D, et al. 2023. Nat Commun. 14:2685. PubMed
  80. Lee K, et al. 2023. JCI Insight. 8:. PubMed
  81. Wang C, et al. 2023. Int J Oral Sci. 15:19. PubMed
  82. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
  83. Scieszka DP, et al. 2023. Respir Res. 24:138. PubMed
  84. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  85. Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed
  86. Urban SK, et al. 2020. Liver Int. 40:3103. PubMed
  87. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  88. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  89. Kokona D, et al. 2016. Exp Eye Res. S0014-4835(16)30499-7. PubMed
  90. Page N, et al. 2018. Immunity. 48:937. PubMed
  91. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  92. Ajina R, et al. 2019. Oncoimmunology. 8:e1577127. PubMed
  93. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  94. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  95. Lyons J, et al. 2018. PLoS Biol. 16:e2002417. PubMed
  96. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  97. Wu SY, et al. 2022. Mol Cancer. 21:84. PubMed
  98. Effern M, et al. 2022. STAR Protoc. 3:101038. PubMed
  99. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  100. Tripathi H, et al. 2020. J Mol Cell Cardiol. 149:95. PubMed
  101. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  102. Radovanovic I, et al. 2014. J Immunol. 193:1290. PubMed
  103. Evans H, et al. 2015. J Immunol. 195: 2973 - 2984. PubMed
  104. Cardona S, et al. 2015. ASN Neuro. 7: 1759091415608204. PubMed
  105. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  106. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  107. Ebneter A, et al. 2017. Transl Vis Sci Technol. 10.1167/tvst.6.2.10. PubMed
  108. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  109. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  110. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  111. Kashyap AS, et al. 2019. Cell Rep. 28:3367. PubMed
  112. Pluchino N, et al. 2020. J Cell Mol Med. 24:2464. PubMed
  113. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  114. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  115. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 5:64. PubMed
  116. Baram T, et al. 2021. Cells. 10:. PubMed
  117. Pan Y, et al. 2021. Front Cell Neurosci. 15:664312. PubMed
  118. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  119. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  120. Adrover JM, et al. 2022. JCI Insight. 7:. PubMed
  121. Steubing RD, et al. 2022. Brain Behav Immun Health. 24:100493. PubMed
  122. Lu H, et al. 2021. Autophagy. 17:2511. PubMed
  123. Kawashima N, et al. 2022. Nat Commun. 13:1624. PubMed
  124. Zhu S, et al. 2022. Front Pharmacol. 13:996635. PubMed
  125. Palacios LM, et al. 2022. Biology (Basel). 11:. PubMed
  126. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  127. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  128. Han Y, et al. 2020. Nat Commun. 11:1776. PubMed
  129. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  130. Haertel E, et al. 2018. Eur J Immunol. 48:1001. PubMed
  131. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  132. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  133. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  134. Zhou X, et al. 2022. Front Pharmacol. 13:887263. PubMed
  135. Biswas S, et al. 2021. Nature. 591:464. PubMed
  136. Khandelwal P, et al. 2013. PLoS One. 8:64193. PubMed
  137. Shibata K, et al. 2014. J Immunol. 192:2210. PubMed
  138. Mantia-Smaldone G, et al. 2014. Gynecol Oncol. 133:584. PubMed
  139. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  140. AR P, et al. 2016. Circ Res. 118: 400-409. PubMed
  141. Zhu B, et al. 2021. Immunity. 54(6):1200-1218.e9. PubMed
  142. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  143. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  144. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  145. Ganeshan K et al. 2019. Cell. 177(2):399-413 . PubMed
  146. Wiley CD, et al. 2019. JCI Insight. 4:e130056. PubMed
  147. Krasteva G, et al. 2011. Proc Natl Acad Sci U S A. 108:9478. PubMed
  148. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  149. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  150. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  151. Armaka M, et al. 2022. Genome Med. 14:78. PubMed
  152. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  153. Jung BG, et al. 2022. PLoS Pathog. 18:e1010454. PubMed
  154. Dieterich LC, et al. 2019. International Journal of Cancer. 145(10):2804-2815. PubMed
  155. Marangoni F, et al. 2021. Cell. . PubMed
  156. Wang LT, et al. 2021. STAR Protocols. 2(1):100337. PubMed
  157. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  158. Chew W, et al. 2016. Nat Methods. 13: 868-874. PubMed
  159. Cordeiro O, et al. 2016. PLoS One. 11: 0151848. PubMed
  160. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  161. Huang B, et al. 2020. Cell. 179(5):1160-1176.e24.. PubMed
  162. Ning F, et al. 2019. J Exp Med. 216:1396. PubMed
  163. Higashi AY, et al. 2019. J Am Soc Nephrol. 30:80. PubMed
  164. Lyons J, et al. 2018. Sci Signal. 11. PubMed
  165. Evans R, et al. 2019. Cell Rep. 27:1967. PubMed
  166. Hammond TR, et al. 2019. Immunity. 50:253. PubMed
  167. Schönfeld M, et al. 2021. Alcohol Clin Exp Res. 45:1980. PubMed
  168. Bhattacherjee A, et al. 2021. Mol Neurodegener. 16:19. PubMed
  169. Bagayoko S, et al. 2021. PLoS Pathog. 17:e1009927. PubMed
  170. Liu M, et al. 2020. Cell Rep. 32:107990. PubMed
  171. Jeljeli M, et al. 2020. Cell Rep. 33:108325. PubMed
  172. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  173. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  174. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  175. Commerford CD et al. 2018. Cell reports. . PubMed
  176. Zeng J, et al. 2019. Cell Rep. 27:549. PubMed
  177. Yousef H, et al. 2018. Bio Protoc. 8:22. PubMed
  178. Willingham SB, et al. 2018. Cancer Immunol Res. 6:1136. PubMed
  179. Weiner AI, et al. 2019. NPJ Regen Med. 4:17. PubMed
  180. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  181. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  182. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  183. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  184. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  185. Donlan AN, et al. 2020. Anaerobe. 66:102275. PubMed
  186. Uher O, et al. 2021. Cancers (Basel). 13:. PubMed
  187. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  188. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  189. Zhang X, et al. 2020. Elife. 9:00. PubMed
  190. JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
  191. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  192. Chun E, et al. 2020. Immunity. 51(5):871-884.e6.. PubMed
  193. Bahar Halpern K, et al. 2020. Nat Commun. 11:1936. PubMed
  194. Soldevilla MM, et al. 2019. Mol Ther. 27:1878. PubMed
  195. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  196. Li Y, et al. 2019. Sci Rep. 9:6932. PubMed
  197. Mifflin L, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  198. Stewart JM, et al. 2020. ACS Biomater Sci Eng. 6:5941. PubMed
  199. Gao H, et al. 2021. Cells. 10:. PubMed
  200. Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed
  201. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  202. Veremeyko T, et al. 2012. J Vis Exp. 65: 4097. PubMed
  203. Fu H, et al. 2020. Front Immunol. 11:595813. PubMed
  204. Oladiran O, et al. 2021. J Neuroinflammation. 77:18. PubMed
  205. Ayaub E,et al. 2017. Sci Rep.. 10.1038/s41598-017-13511-z. PubMed
  206. Peralta Ramos JM, et al. 2017. Front Immunol. 1.490277778. PubMed
  207. Halpern KB, et al. 2018. Nat Biotechnol. 36:962. PubMed
  208. Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed
  209. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  210. Ali M, et al. 2022. JCI Insight. 7:. PubMed
  211. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  212. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  213. Ghandhi SA, et al. 2022. Sci Rep. 12:14124. PubMed
  214. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  215. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  216. McFarland AP, et al. 2021. Immunity. 54(6):1320-1337.e4. PubMed
  217. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  218. Dieterich LC, et al. 2020. Angiogenesis. 1.24375. PubMed
  219. Martina M, et al. 2014. J Vis Exp. 87: 51192. PubMed
  220. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  221. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  222. Haikala HM, et al. 2019. Nat Commun. 10:620. PubMed
  223. Hu Y, et al. 2022. J Nanobiotechnology. 20:417. PubMed
  224. Neuhöfer P, et al. 2021. Nature. 597:715. PubMed
  225. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  226. Hum NR, et al. 2022. Front Oncol. 12:928474. PubMed
  227. Bergin SM, et al. 2021. Brain Behav Immun. 95:477. PubMed
  228. Selvaraj UM, et al. 2021. Brain Behav Immun. 95:502. PubMed
  229. Ying T, et al. 2021. Am J Physiol Endocrinol Metab. 320:E1148. PubMed
  230. Chen Y, et al. 2022. Front Immunol. 13:835690. PubMed
  231. Momin N, et al. 2022. Nat Commun. 13:109. PubMed
  232. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
  233. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  234. Abramowski P, et al. 2014. J Neuroimmunol. 274:111. PubMed
  235. Hoeksema M, et al. 2015. J Immunol. 194:3909. PubMed
  236. Dhanwani R, et al. 2020. Sci Adv. 6:eaba3688. PubMed
  237. Tripathi H, et al. 2020. Stem Cell Rev Rep. 0.953472222. PubMed
  238. Cardenas JJ, et al. 2020. Methods Enzymol. 415:631. PubMed
  239. Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed
  240. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
  241. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  242. Yang Y, et al. 2022. Elife. 11:. PubMed
  243. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  244. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  245. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  246. Gierut J, et al. 2015. Stem Cell Res. 15: 165-171. PubMed
  247. Seki T, et al. 2015. J Biochem. 158: 485 - 495. PubMed
  248. Haka A, et al. 2012. PLoS One. 7:e44823. PubMed
  249. Kaya B, et al. 2020. Cell Reports. 32(5):107979. PubMed
  250. Sztwiertnia I, et al. 2020. PLoS One. 15:e0233789. PubMed
  251. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  252. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  253. Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed
  254. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  255. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  256. Clement CC, et al. 2021. Nat Commun. 12:4447. PubMed
  257. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  258. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  259. Favuzzi E, et al. 2021. Cell. 184(15):4048-4063.e32. PubMed
  260. DiToro D, et al. 2020. Immunity. 650:52. PubMed
  261. Veremeyko T, et al. 2019. J Neurosci Res. 97:162. PubMed
  262. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  263. Kim MY, et al. 2018. Cell. 173:1439. PubMed
  264. Camara A, et al. 2019. Immunity. 50:1467. PubMed
  265. Michaelis KA, et al. 2019. Brain Behav Immun. 82:338. PubMed
  266. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  267. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  268. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  269. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  270. Yu W, et al. 2022. Nat Commun. 13:3544. PubMed
  271. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  272. Ou YC, et al. 2020. ACS Nano. 1.035416667. PubMed
  273. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  274. Zelco A, et al. 2020. Front Cell Neurosci. 0.75625. PubMed
  275. Wang LT, et al. 2020. Cell Rep. 32:108188. PubMed
  276. Hadas R, et al. 2020. JCI Insight. 5:00. PubMed
  277. Stock M, et al. 2015. Osteoarthritis Cartilage. 23: 1221-1225. PubMed
  278. Draper D, et al. 2012. J Immunol. 188:5327. PubMed
  279. Hohsfield LA, et al. 2020. J Neuroinflammation. 0.902083333. PubMed
  280. Godwin MS, et al. 2019. JCI Insight. 4:e126070. PubMed
  281. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  282. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  283. Selvaraj UM et al. 2018. Endocrinology. 159(11):3848-3859 . PubMed
  284. Pinho–Ribeiro FA, et al. 2018. Cell. 173:1083. PubMed
  285. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  286. Hsu M, et al. 2022. Nat Immunol. 23:581. PubMed
  287. Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed
  288. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  289. Wang X, et al. 2022. Front Immunol. 13:864984. PubMed
  290. Galani IE, et al. 2022. STAR Protoc. 3:101151. PubMed
  291. Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed
  292. Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed
  293. Da Mesquita S, et al. 2021. Science Advances. 7(21):. PubMed
  294. Wakabayashi T et al. 2018. Cell stem cell. 22(3):384-397 . PubMed
  295. Kaiser T, et al. 2019. Eneuro. 6. PubMed
  296. El Agha E, et al. 2017. Cell Stem Cell. 1.014583333. PubMed
  297. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  298. Ben-Moshe S, et al. 2019. Nat Metab. 1:899. PubMed
  299. Bhatt D, et al. 2021. J Exp Med. 218:. PubMed
  300. Lu Z, et al. 2021. J Clin Invest. 131:. PubMed
  301. Luo M, et al. 2021. J Immunol. 207:1683. PubMed
  302. Klein S, et al. 2016. J Cell Sci. 129: 2573 - 2585. PubMed
  303. Yu L, et al. 2020. Nat Commun. 2.045833333. PubMed
  304. Liu X, et al. 2019. Mol Cancer Ther. 18:706. PubMed
  305. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  306. Jiang P, et al. 2018. Nat Med. 24:1550. PubMed
  307. Wang X, et al. 2018. Nat Commun. 9:551. PubMed
  308. Li N, et al. 2022. Nat Commun. 13:7281. PubMed
  309. Pedicone C, et al. 2022. iScience. 25:104170. PubMed
  310. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  311. Reda M, et al. 2022. Nat Commun. 13:4261. PubMed
  312. Li Y, et al. 2022. STAR Protoc. 3:101364. PubMed
  313. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  314. Milich LM, et al. 2021. J Exp Med. 218:. PubMed
  315. Kline JM, et al. 2021. J Biol Chem. :100373. PubMed
  316. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  317. Starikova E, et al. 2021. Front Pharmacol. 12:667572. PubMed
  318. Yoldi G, et al. 2016. Cancer Res . 76: 5857 - 5869. PubMed
  319. Ling Y, et al. 2016. Pharmacol Res. S1043-6618(16)31329-9. PubMed
  320. Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed
  321. Lu C, et al. 2020. Cancer Cell. 39(1):96-108.e6. PubMed
  322. Yang C, et al. 2020. Cell Host Microbe. 467:27. PubMed
  323. Armaka M, et al. 2018. Nat Commun. 9:618. PubMed
  324. Lang JF et al. 2019. Nat Commun. 10(1):3415 . PubMed
  325. Theurich S et al. 2017. Cell metabolism. 26(1):171-184 . PubMed
  326. Martin A, et al. 2018. Oncotarget. 9:28364. PubMed
  327. Zhao Y, et al. 2020. Front Immunol. 2.572222222. PubMed
  328. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  329. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  330. Gago-Lopez N, et al. 2019. EMBO Mol Med. 11:e10697. PubMed
  331. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  332. Uluçkan ö, et al. 2020. Cell Reports. 29(4):844-859.e3.. PubMed
  333. Morein D, et al. 2021. Cells. 10: . PubMed
  334. Yan C, et al. 2022. NPJ Precis Oncol. 6:6. PubMed
  335. Phansalkar R, et al. 2021. Elife. 10:. PubMed
  336. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  337. Liu SS, et al. 2021. Immunity. :. PubMed
  338. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  339. E O’Koren, R Mathew, D Saban 2016. Sci Rep. 6:20636. PubMed
  340. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  341. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  342. Seeling M, et al. 2013. Proc Natl Acad Sci U S A. 110:10729. PubMed
  343. Willemze RA, et al. 2019. Mol Med. 25:01:00. PubMed
  344. Fransén Pettersson N, et al. 2018. PLoS One. 13:e0203228. PubMed
  345. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  346. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  347. Peng V, et al. 2022. Nat Immunol. 23:619. PubMed
  348. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  349. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  350. Zhang X, et al. 2022. J Exp Clin Cancer Res. 41:246. PubMed
  351. Guan D, et al. 2021. Cell Death Dis. 12:431. PubMed
  352. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  353. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  354. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  355. Wang X, et al. 2021. Theranostics. 11:209. PubMed
  356. Lux A, et al. 2014. Cell Rep. 10:236. PubMed
  357. Madsen P, et al. 2016. J Neurosci. 36: 5128 - 5143. PubMed
  358. Fox B, et al. 2016. PLoS One. 12: 1006189. PubMed
  359. Parker K, Horn L, Ostrand-Rosenberg S 2016. J Leukoc Biol. 100: 463 - 470.. PubMed
  360. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  361. Dinh HQ, et al. 2020. Immunity. 53(2):319-334.e6. PubMed
  362. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  363. Petriello MC, et al. 2018. Toxicol Sci. 162:548. PubMed
  364. Severe N et al. 2019. Cell Stem Cell. 25(4):570-583 . PubMed
  365. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  366. Forte E, et al. 2020. Cell Rep. 30:3149. PubMed
  367. Wang J, et al. 2020. J Hematol Oncol. 0.610416667. PubMed
  368. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  369. Cong L, et al. 2021. Breast Cancer Res. 23:51. PubMed
  370. De Micheli AJ, et al. 2020. Am J Physiol Cell Physiol. 319:C885. PubMed
  371. Sibler E, et al. 2021. Cells. 10:. PubMed
  372. Oladiran O, et al. 2021. Front Immunol. 12:720733. PubMed
  373. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  374. Sebastian A, et al. 2021. Cells. 10:. PubMed
  375. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  376. Parent AV, et al. 2021. Cell Reports. 36(7):109538. PubMed
  377. Ito Y, et al. 2021. Cell Reports. 35(4):109052. PubMed
  378. Ma Y, et al. 2021. Developmental Cell. 56(4):478-493.e11. PubMed
  379. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
  380. Campisi L, et al. 2016. Nat Immunol. 10.1038/ni.3512. PubMed
  381. Holzapfel B, et al. 2015. Biomaterials. 61: 103-114. PubMed
  382. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  383. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  384. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  385. Swanson WB, et al. 2021. Biomaterials. 272:120769. PubMed
  386. Hohsfield LA, et al. 2021. Elife. 10:. PubMed
  387. Sun D, et al. 2020. PLoS Pathog. 16:e1008361. PubMed
  388. Zhu Q, et al. 2021. J Am Heart Assoc. 10:e023491. PubMed
  389. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
RRID
AB_312980 (BioLegend Cat. No. 103115)
AB_312981 (BioLegend Cat. No. 103116)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD45
Specificity Alt (DOES NOT SHOW ON TDS):
CD45
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about CD45 on UniProt.org

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS UV™ 395 anti-mouse CD45 30-F11 FC
Go To Top Version: 3    Revision Date: 01/30/2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account